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Summary
Background Null mutations within the ﬁlaggrin gene (FLG) cause ichthyosis vulgaris
and are associated with atopic eczema. However, the dermatological features of
ﬁlaggrin haploinsufﬁciency have not been clearly deﬁned.
Objectives This study investigated the genotype–phenotype association between
detailed skin phenotype and FLG genotype data in a population-based cohort of
children.
Methods Children (n = 792) aged 7–9 years were examined by a dermatologist.
Features of ichthyosis vulgaris, atopic eczema and xerosis were recorded and
eczema severity graded using the Three Item Severity score. Each child was geno-
typed for the six most prevalent FLG null mutations (R501X, 2282del4, R2447X,
S3247X, 3702delG, 3673delC). Fisher’s exact test was used to compare genotype
frequencies in phenotype groups; logistic regression analysis was used to estimate
odds ratios and penetrance of the FLG null genotype and a permutation test per-
formed to investigate eczema severity in different genotype groups.
Results Ten children in this cohort had ichthyosis vulgaris, of whom ﬁve had
mild–moderate eczema. The penetrance of FLG null mutations with respect to
ﬂexural eczema was 55Æ6% in individuals with two mutations, 16Æ3% in indi-
viduals with one mutation and 14Æ2% in wild-type individuals. Summating skin
features known to be associated with FLG null mutations (ichthyosis, keratosis
pilaris, palmar hyperlinearity and ﬂexural eczema) showed a penetrance of
100% in children with two FLG mutations, 87Æ8% in children with one FLG
mutation and 46Æ5% in wild-type individuals (P <0 Æ0001, Fisher exact test).
FLG null mutations were associated with more severe eczema (P =0 Æ0042) but
the mean difference was only 1–2 points in severity score. Three distinct pat-
terns of palmar hyperlinearity were observed and these are reported for the ﬁrst
time.
Conclusions Filaggrin haploinsufﬁciency appears to be highly penetrant when all
relevant skin features are included in the analysis. FLG null mutations are associ-
ated with more severe eczema, but the effect size is small in a population setting.
Filaggrin (‘ﬁlament aggregating protein’) is a multifunctional
protein expressed by terminally differentiating keratinocytes.
It aggregates and aligns keratin intermediate ﬁlaments, to
facilitate the collapse of granular layer keratinocytes to pro-
duce squames.
1 Filaggrin is subsequently degraded to release
a mixture of amino acids: these contribute to the natural
moisturizing factor in the stratum corneum;
2 they also
reduce the skin surface pH
3 and provide histidine as a puta-
tive cutaneous ultraviolet photoreceptor.
4 The molecular
structure of ﬁlaggrin includes an S100 calcium-binding
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cium signalling.
5
Loss-of-function (null) mutations within the gene encoding
ﬁlaggrin (FLG) cause ichthyosis vulgaris
6 and are signiﬁcantly
associated with atopic eczema.
7 The strong and signiﬁcant
association of FLG null mutations with atopic eczema has been
demonstrated and replicated in multiple case–control, family-
and population-based studies.
8,9 The strongest and most
highly signiﬁcant associations have been reported with early-
onset, persistent eczema
10,11 (odds ratio 5Æ6, 95% conﬁdence
interval 4Æ1–7Æ8, P =1 Æ3 · 10
)28) and asthma occurring in
individuals with atopic eczema
12–14 (odds ratio 3Æ49, 95%
conﬁdence interval 2Æ00–6Æ08, P =1 Æ0 · 10
)5). Genetic epi-
demiological studies have shown that FLG null mutations are
signiﬁcantly associated with palmar hyperlinearity,
15–17 kerato-
sis pilaris,
17 ﬁne scaling
16,17 and self-reported ‘dry skin’,
16
each of which may be features of ichthyosis vulgaris. How-
ever, the clinical skin phenotype resulting from ﬁlaggrin hap-
loinsufﬁciency (meaning a deﬁciency of ﬁlaggrin as a result of
loss-of-function mutations) has not been clearly deﬁned.
Further analysis of a carefully phenotyped cohort of chil-
dren for whom detailed FLG genotype information is available
provides a useful tool with which to investigate the genotype–
skin phenotype association.
Materials and methods
Skin examination
English school children (n = 792) aged between 7 and 9 years
from an unselected population birth cohort (the North Cum-
bria Community Genetics Project) were examined, each on
one occasion, by an experienced dermatologist (S.J.B.), as part
of a larger genetic epidemiological study, reported previ-
ously.
17 The study was approved by the Local Research Ethics
Committee and a parent or guardian of each child gave writ-
ten informed consent.
Each child’s skin was examined for eczema, features associ-
ated with atopic eczema, ichthyosis and xerosis. Ichthyosis
vulgaris was deﬁned as ﬁne scaling on the extensor surfaces of
the limbs in addition to keratosis pilaris and palmar hyperlin-
earity. Xerosis was deﬁned as skin that was dry to the touch,
but without visible scale, hence the categories of ichthyosis
and xerosis are mutually exclusive. Flexural eczema on exami-
nation was used as the case deﬁnition for this analysis in order
to focus on cases of atopic eczema. Eczema severity was scored
using the Three Item Severity (TIS) score,
18 a simple, validated
scale that allows the rapid assessment and recording of clini-
cally signiﬁcant features: 1–2 represents mild eczema, 3–5
represents moderate eczema and 6–9 represents severe
eczema.
19
For the purposes of this report, we have used the nomen-
clature recommended by the review committee of the World
Allergy Organization,
20 in which ‘eczema’ is used as an
umbrella term to encompass ‘atopic eczema’ and ‘nonatopic
eczema’.
Genetic analysis
A DNA sample from each child was analysed for the six most
prevalent FLG null mutations in the European population
(R501X, 2282del4, R2447X, S3247X, 3702delG and
3673delC) using previously reported methods.
21,22
Statistical analysis
Genotype frequencies in different phenotype groups were
compared by Fisher’s exact test, under the null hypothesis that
there is no association with genotype. Logistic regression anal-
ysis was used to estimate the odds ratio and penetrance of the
FLG null genotype. A permutation test was performed to com-
pare eczema severity scores in the three different genotype
groups (wild-type homozygotes, heterozygotes and individuals
with two FLG null mutations, either homozygous mutants or
compound heterozygotes). Analyses were carried out using
the statistical analysis package Stata (version 9, Stata for Linux;
StataCorp LP, College Station, TX, U.S.A.).
The six screened FLG null mutations were considered to be
a single null allele for the purposes of this analysis; the ratio-
nale for this approach is based on biochemical and immuno-
histochemical evidence that each null mutation produces
truncated forms of proﬁlaggrin which result in a marked
reduction or absence of processed ﬁlaggrin when present in
the homozygote or compound heterozygote state.
6,21
Results
The demographic data and clinical features of the 792 children
are shown in Table 1. Ten children had classical ichthyosis
vulgaris and, among these, ﬁve had ﬂexural eczema (point
prevalence) and three had nonﬂexural as well as ﬂexural
Table 1 Demographic data and clinical features of the skin for 792
English school children aged 7–9 years
Demographic data and
clinical features Number (%)
Sex
Male 405 (51Æ1)
Female 387 (48Æ9)
Flexural eczema 120 (15Æ2)
Ichthyosis vulgaris 10 (1Æ3)
Milder ichthyosis 54 (6Æ8)
Xerosis 193 (24Æ4)
Keratosis pilaris 273 (34Æ4)
Palmar hyperlinearity 167 (21Æ1)
Clinical features are recorded on the basis of skin examination
by a single experienced dermatologist (S.J.B.) and represent
point prevalence. ‘Ichthyosis vulgaris’ is deﬁned as scaly skin on
extensor surfaces plus hyperlinear palms and keratosis pilaris;
‘milder ichthyosis’ is deﬁned as scaly skin as an isolated feature;
‘xerosis’ is deﬁned as clinically dry skin without scaling. All skin
examinations were performed during the winter months.
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ﬂexural eczema. Two of the children with ichthyosis vulgaris
had mild eczema and three had eczema of moderate severity.
As reported previously, FLG null mutations are signiﬁcantly
associated with the predominantly mild–moderate eczema
seen in this cohort.
17 Our study utilized an unselected popula-
tion cohort and hence the true risk or penetrance of FLG null
mutations can be assessed, i.e. the proportion of individuals
with a given genotype having a given phenotype.
These data demonstrate that the penetrance of FLG null
mutations with respect to ﬂexural eczema in this cohort is
55Æ6% in homozygotes and 16Æ3% in heterozygotes, compared
with 14Æ2% in wild-type homozygotes. The penetrance with
respect to skin signs known to be associated with FLG haploin-
sufﬁciency
15–17 (summing ichthyosis, keratosis pilaris, palmar
hyperlinearity and ﬂexural eczema) is 100% in homozygotes,
87Æ8% in heterozygotes and 46Æ5% in wild-type homozygotes
(P <0 Æ0001, Fisher exact test). Xerosis is not included in this
grouped analysis as xerosis as a skin sign (meaning clinically
dry skin in the absence of scaling) is not independently associ-
ated with FLG null mutations.
17 The equivalent odds ratios for
FLG-related skin features are > 100 in FLG null homozygotes
and 6Æ3i nFLG heterozygotes, compared with 1Æ0 in wild-type
individuals. Furthermore, in this cohort the association of FLG
null mutations with the combined ichthyosis and⁄or keratosis
pilaris and⁄or hyperlinear palms and⁄or eczema group persists
when the 10 cases of ichthyosis vulgaris are excluded from
analysis (P <0 Æ0001).
Of the 778 children for whom FLG genotype data were
available for all six of the screened mutations, there was one
homozygote, eight compound heterozygotes (i.e. children car-
rying two different FLG null alleles) and 98 heterozygotes.
None of the nine children with two FLG mutations had
entirely normal skin: ﬁve had eczema, seven had classical
ichthyosis vulgaris (including hyperlinear palms and keratosis
pilaris) and the remaining two had milder ichthyosis. Skin
signs observed in the 98 heterozygous children are summa-
rized in Table 2. Only 10 of the 98 heterozygotes (10Æ2%)
had clinically normal skin, whereas 281 of the 671 (41Æ9%)
homozygous wild-type individuals had normal skin, a statistic-
ally signiﬁcant difference (P <0 Æ0001).
The column chart in Figure 1 shows the eczema severity
scores in children with ﬂexural eczema having different FLG
genotypes. The chart illustrates that children with one or more
FLG null mutation tended to have more severe eczema: a
permutation test comparing the three genotype groups –
wild-type homozygotes, heterozygotes and FLG null homozyg-
otes – shows that this difference is statistically signiﬁcant
(P =0 Æ0042, comparing all three groups).
Examination of such a large number of children led to the
novel observation that there are several distinct patterns of
palmar hyperlinearity, illustrated diagrammatically in Figure 2.
The vast majority of children in this cohort had smooth
palmar skin; some children had a subtle increase in palmar
markings at the margins of the thenar eminence, but this was
not classiﬁed as palmar hyperlinearity for the purposes of this
Table 2 Skin phenotypes and clinical features in 778 children with
different ﬁlaggrin null genotypes
Skin phenotype or
clinical feature
FLG null
homozygotes
a
(n = 9),
n (%)
FLG null
heterozygotes
(n = 98),
n (%)
FLG wild-type
homozygotes
(n = 671),
n (%)
Flexural eczema 5 (55Æ6) 16 (16Æ3) 95 (14Æ2)
Ichthyosis vulgaris 9 (100) 3 (3Æ1) 0 (0)
Milder ichthyosis 2 (22Æ2) 23 (23Æ5) 30 (4Æ5)
Xerosis 0 (0) 32 (32Æ7) 163 (24Æ3)
Keratosis pilaris 9 (100) 59 (60Æ2) 201 (30Æ0)
Hyperlinear palms 9 (100) 73 (74Æ5) 84 (12Æ5)
Clinically normal
skin
0 (0) 10 (10Æ2) 281 (41Æ9)
Genotyping results for all six of the screened mutations (R501X,
2282del4, R2447X, S3247X, 3702delG, 3673delC) were avail-
able for these 778 children out of the 792 children included in
this cohort study. Analysis is performed using a combined null
genotype, in which the different FLG null mutations are consid-
ered to be equivalent, on the basis of their equivalent effects
demonstrated in previous biochemical and immunohistochemi-
cal studies.
21 aThe group of FLG null homozygotes includes one
R501X homozygote and eight compound heterozygotes.
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Fig 1. Column chart to illustrate the eczema severity scores of 778
children with different ﬁlaggrin genotypes. TIS score, Three Item
Severity score,
18 where a score of 1–2 represents mild eczema, 3–5
moderate and 6–9 severe disease.
19 *Individuals with two FLG null
mutations include one homozygote (with two copies of the R501X
null mutation) and seven compound heterozygotes (with two
different null mutations). A permutation test demonstrates that there
is a signiﬁcant difference in eczema severity when the three genotype
groups are compared (P =0 Æ0042).
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were deﬁned after examination of 484 children; in the subse-
quent series of 308 children, 65 cases of palmar hyperlinearity
were observed. Within this series, the majority of children
(40 of 65; 62%) showed pattern 3, and roughly equal num-
bers showed pattern 1 (12 of 65; 18%) and pattern 2 (13 of
65; 20%). Pattern 1 predominated in the children with ichthy-
osis vulgaris (seen in four of ﬁve children with ichthyosis vul-
garis). Pattern 3 was most common in children with eczema
(seen in 10 of 21 eczema cases) but it was also frequently
observed in children with otherwise normal skin (29 of 39
children with normal skin in this series).
Discussion
The causal association of FLG null mutations with ichthyosis
vulgaris has previously been demonstrated by pedigree exami-
nation, histological and biochemical data,
6 and a strongly sig-
niﬁcant association with atopic eczema has been established
using genetic epidemiology.
9,23 However, this study furthers
our understanding of the skin phenotype associated with ﬁlag-
grin haploinsufﬁciency in two main ways: ﬁrstly, the strong
penetrance of eczema, ichthyosis and associated skin signs in
different FLG genotypes is demonstrated in an unselected
population; and secondly, the inﬂuence of FLG null mutations
on eczema severity is assessed.
Use of an unselected population-based cohort allows esti-
mation of the true risk or penetrance of FLG null mutations,
rather than the relative risk which can be estimated from
case–control studies or atopy-related cohorts. The penetrance
of FLG null mutations with respect to ﬂexural eczema as a
point prevalence is 55Æ6% in homozygotes and compound
heterozygotes and 16Æ3% in heterozygotes, but the penetrance
in heterozygotes is not signiﬁcantly different from wild-type
individuals, at 14Æ2%. The use of point prevalence of eczema
as a case deﬁnition would almost certainly have led to an
underestimation of the eczema penetrance in each genotype
group, because of the relapsing and remitting nature of the
disease. In contrast, the point prevalence of the more stable
clinical signs such as keratosis pilaris and palmar hyperlinearity
is more representative of the population period prevalence.
Summation of ichthyosis, keratosis pilaris, palmar hyperlinear-
ity and ﬂexural eczema, to take into account all the skin fea-
tures which may be associated with FLG null mutations,
suggests a highly penetrant haploinsufﬁciency: 100% of indi-
viduals with two FLG null mutations and 87Æ8% of individuals
with one FLG null mutation show one or more of these skin
features, compared with 46Æ5% of wild-type individuals, a
statistically signiﬁcant difference (P <0 Æ0001, Fisher exact
test). Furthermore, this signiﬁcant difference persists when the
10 ichthyosis vulgaris cases are removed from the analysis,
indicating that the effect is not purely driven by ichthyosis
vulgaris. These observations are consistent with a semidomi-
nant pattern of inheritance in which the FLG null hetero-
zygotes exhibit a milder skin phenotype than the FLG null
homozygotes.
7
The ﬁnding that 85–100% of individuals carrying one or
more FLG null mutations may demonstrate signs of ﬁlaggrin
haploinsufﬁciency is striking (notwithstanding a limitation to
this study in that only the six most prevalent FLG null muta-
tions were examined) although the clinical signs are often
asymptomatic. However, incomplete penetrance (< 100%)
implies that other factors – both genetic and environmental –
modulate the effects of ﬁlaggrin haploinsufﬁciency, particu-
larly in eczema where the penetrance is much lower than in
the ichthyosis⁄keratosis pilaris⁄palmar hyperlinearity⁄eczema
group used for the combined analysis. Experimental evidence
for such genetic and environmental modulation includes the
Pattern not classified as
palmar hyperlinearity
for the purposes of
this study 
Palmar
hyperlinearity
pattern 1 
Palmar
hyperlinearity
pattern 2 
Palmar
hyperlinearity
pattern 3
Fig 2. Diagrammatic representation of the patterns of palmar skin markings observed in a series of 308 English school children aged 7–9 years.
The palmar skin features of a total of 792 children were examined by a single experienced dermatologist (S.J.B.). Examination of 484 children led
to the observation of three distinct patterns of palmar hyperlinearity and the patterns of palmar markings were then recorded for the subsequent
308 children. The majority of children in this cohort had very smooth palmar skin; within the series of 308 children, 65 had palmar
hyperlinearity of whom 18% showed pattern 1, 20% showed pattern 2 and 62% showed pattern 3. Diagrams have been used to illustrate the
hyperlinearity patterns as clinical photos were not permitted because of ethical constraints, but examples of the distinct patterns may be seen in
published literature.
6,22,36–39
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Skin signs with ﬁlaggrin haploinsufﬁciency, S.J. Brown et al. 887demonstration that cytokines from Th2 cells can downregulate
ﬁlaggrin expression in atopic eczema skin;
24 in addition, sev-
eral different mouse models have demonstrated that mutations
in other genes encoding stratum corneum proteins can affect
ﬁlaggrin expression and⁄or processing.
25–29
The cellular and molecular mechanisms by which ﬁlaggrin
deﬁciency results in skin features such as palmar hyperlinearity
and keratosis pilaris remain to be deﬁned. It is noteworthy
that approximately 46Æ5% of FLG wild-type individuals
also demonstrated ichthyosis, keratosis pilaris, palmar hyper-
linearity and⁄or eczema, which may be a result of ﬁlaggrin
downregulation by other genetic and⁄or environmental factors
or by ﬁlaggrin-independent mechanisms. The mechanisms by
which ﬁlaggrin deﬁciency may result in ‘dry skin’ have been
discussed.
30,31 The fact that FLG haploinsufﬁciency is not
independently associated with xerosis per se in this cohort
17
may conﬂict with the hypothesis that FLG null mutations result
in dry skin because of a dose reduction in hygroscopic amino
acids,
30,31 the so-called ‘natural moisturizing factor’.
To date only two studies have attempted to investigate
whether eczema severity is associated with the presence or
absence of FLG null mutations.
32,33 This is a reﬂection of the
fact that most FLG-related data have been generated from stud-
ies of moderate–severe cases, excluding children with mild
disease. In contrast, our cohort study generates data relating
predominantly to mild–moderate eczema cases, with very few
(n = 5) severe cases, none of whom was an FLG null homo-
zygote or compound heterozygote. Our analysis comparing
severity scores between genotype groups does show a signiﬁ-
cant difference across all three groups (P =0 Æ0042, permuta-
tion test). This is in keeping with the analysis by Morar et al.,
which showed a signiﬁcant association between FLG genotype
and eczema severity (P =0 Æ007 with the linear regression
model).
32 The only other reported analysis showed no signiﬁ-
cant association between the combined SPINK5, KLK7 and FLG
null genotype although the numbers were small (n = 99).
33
However, the ﬁnding of a statistically signiﬁcant association
does not necessarily imply a clinically signiﬁcant association.
In the study cited above (Morar et al.) it was estimated that
FLG had only a very minor effect on eczema severity
(R
2 =0 Æ8%).
32 Similarly in our study, the mean eczema sever-
ity score is 1Æ8 in the group with two FLG null mutations
compared with 0Æ4 in wild-type homozygotes, and the clinical
relevance of a difference of 1–2 points on the TIS score is
likely to be marginal. However, it has not been formally
assessed in terms of quality of life or patient symptoms.
Keratosis pilaris and palmar hyperlinearity are each indepen-
dently associated with FLG null mutations in this cohort.
17 The
association may be coincidental, as keratosis pilaris and hyper-
linear palms are both features of ichthyosis vulgaris,
34,35 but
this is unlikely as the statistical association persists after
excluding the ichthyosis vulgaris cases. The novel observation
that there are three distinct patterns of palmar hyperlinearity
merits further investigation: it may help to clarify the ultra-
structural mechanisms by which ﬁlaggrin haploinsufﬁciency
results in hyperlinearity, as the pattern of linear markings
running perpendicular to the thenar eminence (pattern 1,
Fig. 2) predominates in cases of ichthyosis vulgaris, although
the cross-hatched pattern (pattern 3, Fig. 2) is more prevalent
overall. These different patterns may be observed in previously
published photographs: pattern 1 is shown by O’Regan and
Irvine (Fig. 1b)
36 and Judge et al.;
37 pattern 2 is demonstrated
by Nomura et al. (Figs 2c and 2d);
38 while pattern 3 is dem-
onstrated by Smith et al. (Figs 1c and 1e),
6 Sandilands et al.
(Fig. 1b)
22 and Chen et al. (Figs 1a and 1b).
39
In conclusion, ﬁlaggrin haploinsufﬁciency is a highly pene-
trant trait, associated with ichthyosis, keratosis pilaris, palmar
hyperlinearity and ﬂexural eczema, with a statistically signiﬁ-
cant trend towards more severe eczema. A greater understand-
ing of the complex skin phenotype resulting from ﬁlaggrin
deﬁciency may in the future facilitate the development and
appropriate application of novel therapeutic strategies.
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